INNT
TOTAL INVALIDATION PROCESSED BY THE IB
22/08/2025
Voltar para busca
Dado oficial do USPTO
POLYPHOR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
23/08/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
10/03/2017
Data de registro
06/02/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/08/2024
Última transação
23/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
DANG, PETER
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Polyphor AG
Representantes
Scott D. Woldow Smith, Gambrell, Russell, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industryscienceagriculturehorticulture and silvicultureexcept fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resinsunprocessed plastics; soil fertilizers; chemical substances for preserving foodstuffsfood preservatives; adhesives used in industry
Classe 5
Pharmaceuticalveterinary and sanitary productsPharmaceutical anti-allergic preparations and substancesPharmaceutical for the treatment of erectile dysfunctionPharmaceutical preparationsanticoagulantsPharmaceutical preparationsantidepressantsPharmaceutical preparationsappetite suppressantsPharmaceutical preparations for use in chemotherapyPharmaceutical preparation for the treatment of goutPharmaceutical preparations for the treatment of heart rhythm disordersPharmaceutical preparations for the treatment of stem cell mobilizationPharmaceutical preparations for the treatment of infectious diseasesPharmaceutical preparations acting on the central nervous systemPharmaceutical preparations and substances for the treatment of gastro-intestinal diseasesPharmaceutical preparations for animal skincarePharmaceutical preparations for inhalation for the treatment of pulmonary hypertensionPharmaceutical preparations for ocular or intraocular surgeryPharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosisPharmaceutical preparations for treating allergic rhinitis and asthmaPharmaceutical preparations for treating diabetesPharmaceutical preparations for treating skin disordersPharmaceutical preparations for use in dermatologyPharmaceutical preparations for woundsPharmaceutical preparations for use in urologyPharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicinePharmaceutical products and preparations against dry skin caused by pregnancyPharmaceutical products and preparations for chloasmaPharmaceutical products and preparations for hydrating the skin during pregnancyPharmaceutical products and preparations for pregnancy blemishesPharmaceutical products and preparations for preventing skin blemishes during pregnancyPharmaceutical products and preparations to prevent stretch marksPharmaceutical products and preparations to prevent swelling in the legsPharmaceutical products for ophthalmological usePharmaceutical products for skin care for animalsPharmaceutical products for the treatment of bone diseasesPharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancerPharmaceutical products for treating respiratory diseases and asthmaPharmaceutical skin lotionsPharmaceutical solutions used in dialysisPharmaceuticalsantihelminticsPharmaceuticalsinducers of erectionsPharmaceuticalslipid lowering agentsPharmaceuticalspsychotropicsPharmaceuticalsanti-infectives; Veterinary preparationspain relief medicationveterinary preparations for the treatment of intestinal bacteriaVeterinary vaccine for horsesVeterinary vaccines; sanitary preparations for medical purposes; disinfectants; products for destroying verminvermin destroying preparations; fungicidesherbicides
Classe 42
Researchconsultancyproduct development based on internal and customer data in the field chemistry regarding chemicals and resins; Planning of information technology systems for others based on internal and customer data in the field chemistry for researching chemicals and resins
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/08/2025
INPC
INVALIDATION PROCESSED
06/08/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
23/04/2025
C71T
CANCELLED SECTION 71
23/08/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/02/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/10/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/05/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
24/01/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/07/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/06/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/05/2018
FIMP
FINAL DISPOSITION PROCESSED
14/05/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/05/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2018
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
22/01/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
24/11/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/11/2017
PUBO
PUBLISHED FOR OPPOSITION
21/11/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/11/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/09/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/09/2017
RFNT
REFUSAL PROCESSED BY IB
11/08/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/07/2017
RFRR
REFUSAL PROCESSED BY MPU
27/07/2017
MAFR
APPLICATION FILING RECEIPT MAILED
25/07/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/07/2017
CNRT
NON-FINAL ACTION WRITTEN
20/07/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
19/07/2017
DOCK
ASSIGNED TO EXAMINER
19/07/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/07/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
14/07/2017
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
13/07/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace POLYPHOR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.